Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity

被引：0
|
作者：
Thomas Mandl
Jan Marsal
Peter Olsson
Bodil Ohlsson
Kristofer Andréasson
机构：
[1] Lund University,Section of Rheumatology, Department of Clinical Sciences Malmö
[2] Skane University Hospital,Department of Gastroenterology
[3] Lund University,Immunology Section, Department of Experimental Medical Science
[4] Lund University,Section of Medicine, Department of Clinical Sciences Lund
[5] Lund University,Section of Internal Medicine, Department of Clinical Sciences Malmö
[6] Lund University,Section of Rheumatology, Department of Clinical Sciences Lund
[7] Skane University Hospital Malmö,Department of Rheumatology
来源：
Arthritis Research & Therapy | / 19卷
关键词：
Primary Sjögren’s syndrome; Microbiome; Gastrointestinal; Dysbiosis; Disease activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Severe intestinal dysbiosis is prevalent in primary Sjogren's syndrome and is associated with systemic disease activity
    Mandl, Thomas
    Marsal, Jan
    Olsson, Peter
    Ohlsson, Bodil
    Andreasson, Kristofer
    [J]. ARTHRITIS RESEARCH & THERAPY, 2017, 19 : 237
  • [2] Sjögren’s syndrome: a systemic autoimmune disease
    Simone Negrini
    Giacomo Emmi
    Monica Greco
    Matteo Borro
    Federica Sardanelli
    Giuseppe Murdaca
    Francesco Indiveri
    Francesco Puppo
    [J]. Clinical and Experimental Medicine, 2022, 22 : 9 - 25
  • [3] Identification of definitive serum biomarkers associated with disease activity in primary Sjögren’s syndrome
    Ayumi Nishikawa
    Katsuya Suzuki
    Yoshiaki Kassai
    Yuumi Gotou
    Maiko Takiguchi
    Takahiro Miyazaki
    Keiko Yoshimoto
    Hidekata Yasuoka
    Kunihiro Yamaoka
    Rimpei Morita
    Akihiko Yoshimura
    Tsutomu Takeuchi
    [J]. Arthritis Research & Therapy, 18
  • [4] Renal Disease in Primary Sjögren’s Syndrome
    Oshorenua Aiyegbusi
    Laura McGregor
    Lucy McGeoch
    David Kipgen
    Colin C. Geddes
    Kathryn I. Stevens
    [J]. Rheumatology and Therapy, 2021, 8 : 63 - 80
  • [5] Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome
    Lin Weng
    Yaqiong Chen
    Tao Liang
    Yihua Lin
    Dehao Liu
    Ciyong Yu
    Yudi Hu
    Wei Lui
    Yongliang Liu
    Xiangfang Chen
    Qiyuan Li
    Shengxiang Ge
    Dana P. Ascherman
    Juan Chen
    [J]. European Journal of Medical Research, 27
  • [6] Hematologic parameters and disease activity in patients with primary Sj?gren?s syndrome
    Moghaddam, Azadeh Abbasi
    Saremi, Zeinab
    Atabati, Elham
    Sharifzadeh, Gholamreza
    [J]. EGYPTIAN RHEUMATOLOGIST, 2022, 44 (04): : 329 - 332
  • [7] Persistent serological activity in primary Sjögren’s syndrome
    Jorge López-Morales
    Daniel Cortes-Muñoz
    Miguel Astudillo-Ángel
    Gabriela Hernández-Molina
    [J]. Clinical Rheumatology, 2020, 39 : 919 - 923
  • [8] Topical and systemic medications for the treatment of primary Sjögren's syndrome
    Manuel Ramos-Casals
    Pilar Brito-Zerón
    Antoni Sisó-Almirall
    Xavier Bosch
    Athanasios G. Tzioufas
    [J]. Nature Reviews Rheumatology, 2012, 8 : 399 - 411
  • [9] Interstitial lung disease in Primary Sjögren's syndrome
    Wei Lin
    Zhifei Xin
    Jianlong Zhang
    Ning Liu
    Xiuying Ren
    Meilu Liu
    Yashuang Su
    Yixuan Liu
    Liu Yang
    Shaoying Guo
    Yupeng Yang
    Yang Li
    Jingjing Cao
    Xiaoran Ning
    Jingjing Li
    He Xue
    Nannan Niu
    Yingmin Chen
    Fang Li
    Lijun Sun
    Xiaopeng Zhang
    Fengxiao Zhang
    Wen Zhang
    [J]. BMC Pulmonary Medicine, 22
  • [10] Gut microbial dysbiosis in individuals with Sjögren’s syndrome
    Roberto Mendez
    Arjun Watane
    Monika Farhangi
    Kara M. Cavuoto
    Tom Leith
    Shrish Budree
    Anat Galor
    Santanu Banerjee
    [J]. Microbial Cell Factories, 19
12345